학술논문
Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages
Document Type
Article
Author
Gomez-Roca, C.A. ; Italiano, A. ; Le Tourneau, C.; Cassier, P.A.; Toulmonde, M.; D’Angelo, S.P.; Campone, M.; Weber, K.L.; Loirat, D.; Cannarile, M.A.; Jegg, A.-M.; Ries, C.; Christen, R.; Meneses-Lorente, G.; Jacob, W.; Klaman, I.; Ooi, C.-H.; Watson, C.; Wonde, K.; Reis, B.; Michielin, F.; Rüttinger, D.; Delord, J.-P.; Blay, J.-Y.
Source
In Annals of Oncology August 2019 30(8):1381-1392
Subject
Language
ISSN
0923-7534